#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Monogenic diabetes Anti-myelin-associated glycoprotein antibodies positive Familial dilated cardiomyopathy Chondrodystrophy Thrombotic thrombocytopenic purpura Chronic graft versus host disease in skin Adult T-cell lymphoma/leukaemia refractory Acute myeloid leukaemia recurrent Ventricular tachycardia Iron overload Central nervous system neoplasm Cystic fibrosis lung Neuroendocrine tumour Osteosarcoma recurrent Andersen-Tawil syndrome More trials…

    Learn about Rare Diseases

    Rett syndrome – Treatment Idiopathic inflammatory myopathy Lennox-Gastaut syndrome – Trials in Disease Langerhans’ cell histiocytosis – Diagnostics Idiopathic inflammatory myopathy – Basic Information Breast angiosarcoma – Treatment Acute respiratory distress syndrome – Diagnostics Undifferentiated sarcoma – Life with Disease Bronchopulmonary dysplasia – Life with Disease Von Willebrand’s disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Inupadenant ALENDRONATE SODIUM TRIHYDRATE 177LU-PSMA-I&T Atl001 Vindesine Sulfate Siponimod Fumaric Acid Naloxegol Oxalate Lutetium (177Lu) Edotreotide Azd5462 M-(18F)-Fluorobenzylguanidine INSULIN DEGLUDEC Empasiprubart Vib1116 Deferoxamine Mesilate (-)-PHENSERINE TARTRATE Bendamustine Hydrochloride Barzolvolimab Pegfilgrastim Rebisufligene Etisparvovec Istaroxime More therapies…

    Learn about Your Condition

    Retroperitoneal fibrosis Systemic lupus erythematosus Organ donor Chondrosarcoma metastatic Haemolytic uraemic syndrome Malignant melanoma stage IV Pyelonephritis Primary hypogonadism Vomiting Thalassaemia alpha Hepatitis D Hypoxia Hepatitis B Intervertebral disc protrusion Hepatobiliary cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Systemic lupus erythematosus

  • Study on Long-Term Safety of Cenerimod for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cenerimod
    Bulgaria Czechia France Germany Greece Poland +3

  • Study on the Effects of Rapcabtagene Autoleucel in Patients with Systemic Lupus Erythematosus and Active, Refractory Lupus Nephritis

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Belimumab
    • Fludarabine Phosphate
    • Mycophenolic Acid
    Austria Czechia Denmark France Germany Hungary +7

  • Study on Steroid Withdrawal in Systemic Lupus Erythematosus Patients Using Prednisone

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Prednisone
    Italy

  • Study on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Tenofovir Disoproxil
    Bulgaria Czechia France Germany Hungary Italy +5

  • Study on the Effects of Abacavir and Lamivudine in Patients with Systemic Lupus Erythematosus with Low Disease Activity

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Abacavir
    • Lamivudine
    France

  • Study of Anifrolumab for Children and Teens with Moderate to Severe Lupus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Anifrolumab
    France Germany Italy Poland Portugal Spain
Previous Page
1 2 3 4 5 … 10
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!